22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A rare case of ruptured infrarenal aortic aneurysm infected with Haemophilus influenzae type B

      research-article
      , MD MSc, , MD FRCSC
      The Canadian Journal of Infectious Diseases & Medical Microbiology
      Pulsus Group Inc

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CASE PRESENTATION A 56-year old woman presented to the emergency department with a vague history of abdominal pain that had persisted for five days. A long-standing smoker, she was otherwise healthy with no previously diagnosed chronic medical conditions, and had no recent exposure to any sick contacts; she did admit to having a short episode of an upper respiratory tract infection two weeks previously that self-resolved. There was also no recent history of travel. On examination, she was tachycardic (110 beats/min to 115 beats/min), hypertensive (169/110 mmHg) and afebrile, and had a soft but tender abdomen. White blood cell count was in the 20×109/L range. Computed tomography (CT) angiography of the abdomen and pelvis revealed a 4 cm infrarenal aortic aneurysm extending to the aortic bifurcation with an associated 6.4 cm × 10 cm periaortic hematoma suggestive of rupture (Figure 1). The renal arteries and visceral vessels displayed mild atheromatous changes; other intra-abdominal structures were unremarkable. The patient’s relatively young age and female sex, coupled with the relatively small size and inflammatory appearance of the ruptured aneurysm on CT scan, were highly suggestive of a mycotic aneurysm. Blood cultures were drawn and ciprofloxacin and cefazolin were initiated. The patient was brought to the operating room for emergent open repair through a midline transperitoneal approach. Intraoperatively, note was made of an edematous retroperitoneum and an adherent duodenum. There were significant inflammatory changes in the aorta, extending distally into the iliac arteries. The periaortic fluid was noted to be nonpurulent; a sample of this was sent for Gram stain, and was reported as “moderate polymorphs with no organisms seen”. Given these nonspecific findings, the aneurysm was repaired with an in situ aorto-bi-iliac 12 mm × 7 mm Hemashield graft. The patient was then transferred to the intensive care unit (ICU) for postoperative care and continued on ciprofloxacin and cefazolin. Recovery was complicated, however, with acute occlusion of the graft. The patient underwent a second surgery with extensive thrombectomy of both limbs of the graft, as well as a left iliofemoral bypass due to consistently poor flow. The patient continued to decline, requiring increasing pressors to maintain hemodynamics. Antibiotics were broadened to include meropenem, vancomycin and fluconazole to treat her sepsis, despite negative blood cultures drawn at the time of the initial presentation. Additional complications included the need for hemodialysis for renal failure. DIAGNOSIS Culture results from the aneurysm sac were reported four days after the initial surgery, and subtyping was performed shortly thereafter. The aneurysm sac was infected with Haemophilus influenzae type B. A subsequent CT scan 19 days into admission revealed evidence of free air under the diaphragm, as well as around the graft itself. Exploratory laparotomy revealed a perforated colon with gross graft contamination with stool and pus; a subtotal colectomy was performed with the creation of an end-ileostomy and the graft was heavily irrigated. Bilateral axillofemoral grafts were placed in a subsequent surgery with 8 mm ringed polytetrafluoroethylene. Four days later, the patient underwent explantation of the infected graft; intraoperatively, the bowel was also noted to be edematous and friable, resulting in two inadvertent enterotomies requiring additional surgeries for repair. In total, the patient underwent nine separate operations in a span of two months. She also required a tracheostomy in the ICU for prolonged ventilation over this time. Additionally, her postoperative neurological function was compromised due to the development of new-onset lumbar plexopathy. With ongoing medical care as well as physiotherapy support, she recovered slowly and was discharged to the floor from ICU on postoperative day 82; her antibiotics were discontinued on postoperative day 91. She was eventually discharged to her home hospital for planned rehabilitation on postoperative day 120. DISCUSSION The present report outlines the life-threatening nature of this rare, but devastating disease. Infected aneurysms are generally classified under five different subtypes: mycotic aneurysms from septic emboli; microbial arteritis secondary to bacteremia; infection of a pre-existing aneurysm; contiguous spread of infection from an adjacent septic site; and post-traumatic or iatrogenic false aneurysm. The most common species implicated are Salmonella and Staphylococcus (1–3). Furthermore, patients with infected aneurysms are generally severely comorbid and present with coexisting sepsis (4). H influenzae is a very rare causative agent for mycotic aneurysms. Children in North America are routinely vaccinated against type B, which is one of the most virulent encapsulated strains (5). There are only four previous cases in English literature of infected aneurysms caused by H influenzae type B from Europe and Asia (4,6–8). To our knowledge, this represents the first reported case in North America. We believe that the patient likely had a type 2 or a type 3 mycotic aneurysm. In other words, she had a pre-existing aneurysm that became infected, possibly from her episode of upper respiratory tract infection two weeks previously; less likely, she had an episode of bacteremia in the past, resulting in aortitis. Additionally, the patient was relatively healthy on initial presentation, with no fever and negative blood cultures, in contrast to the classical symptoms described by Reddy et al (9). Although a small sample size, the present report, along with previously reported cases (4,6,8), suggest that the organism results in more subtle and insidious infections than Salmonella and Staphylococcus species. This favours a low threshold for suspecting infected aortic aneurysms. In the present patient, the key factors included her relatively young age, the absence of any known vascular pathology, the significant inflammatory nature of the aorta and the progression to rupture before any suspicious signs. The presence of the upper respiratory tract infection two weeks previously may also be significant, although it is an unreliable finding. In retrospect, the decision to place an in situ aorto-bi-iliac synthetic graft resulted in significant patient morbidity, despite ongoing treatment with antibiotics. Previous reports suggest that in situ bypasses are a viable option in an infected field as long as there is no gross contamination with pus or obvious purulence (10). The clinical course of the present patient fuels the debate on the value of creating an extra-anatomic bypass from the outset. Mycotic aneurysms, while rare, represent an ongoing challenge in the field of vascular surgery. The presence of H influenzae type B as a causative organism is even rarer in the literature, and patients with mycotic aneurysms secondary to this organism present with a clinical picture that is more subtle than what is commonly known from previously described reports. Therefore, it is important to have a low threshold for initiating rapid medical treatment in the form of antibiotics and to consider a variety of surgical approaches in a suspected infected field.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results.

          Infected aortic aneurysms are rare, difficult to treat, and associated with significant morbidity. The purpose of this study was to review the management and results of patients with infected aortic aneurysms and identify clinical variables associated with poor outcome. The clinical data and early and late outcomes of 43 patients treated for infected aortic aneurysms during a 25-year period (1976-2000) were reviewed. Variables were correlated with risk of aneurysm-related death and vascular complications, defined as organ or limb ischemia, graft infection or occlusion, and anastomotic or recurrent aneurysm. Infected aneurysms were infrarenal in only 40% of cases. Seventy percent of patients were immunocompromised hosts. Ninety-three percent had symptoms, and 53% had ruptured aneurysms. Surgical treatment was in situ aortic grafting (35) and extra-anatomic bypass (6). Operative mortality was 21% (9/42). Early vascular complications included ischemic colitis (3), anastomotic disruption (1), peripheral embolism (1), paraplegia (1), and monoparesis (1). Late vascular complications included graft infection (2), recurrent aneurysm (2), limb ischemia (1), and limb occlusion (1). Mean follow-up was 4.3 years. Cumulative survival rates at 1 year and 5 years were 82% and 50%, respectively, significantly lower than survival rates for the general population (96% and 81%) and for the noninfected aortic aneurysm cohort (91% and 69%) at same intervals. Rate of survival free of late graft-related complications was 90% at 1 year and 5 years, similar to that reported for patients who had repair of noninfected abdominal aortic aneurysms (97% and 92%). Variables associated with increased risk of aneurysm-related death included extensive periaortic infection, female sex, Staphylococcus aureus infection, aneurysm rupture, and suprarenal aneurysm location (P <.05). For risk of vascular complications, extensive periaortic infection, female sex, leukocytosis, and hemodynamic instability were positively associated (P <.05). Infected aortic aneurysms have an aggressive presentation and a complicated early outcome. However, late outcome is surprisingly favorable, with no aneurysm-related deaths and a low graft-related complication rate, similar to standard aneurysm repair. In situ aortic grafting is a safe and durable option in most patients.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            In situ prosthetic graft replacement for mycotic aneurysm of the aorta.

            Mycotic aneurysms as defined in this study include only those naturally occurring aortic aneurysms that result from or are secondarily infected by bacteria arising in a distant site of infection. Of the 2,585 patients treated for aortic aneurysm during the past 8 1/2 years, 22 patients had disease conforming to this definition. The aneurysms were located in the ascending aorta in 2 patients, ascending aorta and arch in 5, arch and descending aorta in 1, descending thoracic aorta in 1, separate descending and abdominal aorta in 1, thoracoabdominal aorta in 5, upper abdominal aorta in 6, and infrarenal abdominal aorta in 1. The primary source of infection was the urinary tract in 2 patients, salmonellosis in 4, pneumonia in 3, sub-acute bacterial endocarditis in 2, ear, nose, and throat in 2, cellulitis of the hand in 1, chronic wounds in 2, dental extraction in 1, lumbar disc space infection in 1, septic thrombophlebitis in 1, and generalized febrile illness in 3. The duration of febrile illness ranged from 2 weeks to 1 year. All patients were treated with antibiotics and operation was performed within 24 hours after admission in 11 patients and within one to eight days after admission in 11. Treatment consisted of in situ graft replacement. Appropriate antibiotics were given intravenously for 4 to 6 weeks in patients with positive cultures and continued orally for the rest of the patients' lives. Of the 22 patients, 19 (86%) were early survivors, and all are still alive 3 months to 8 years postoperatively. Only 1 had a recurrent infection, which involved the intervertebral disc space.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Management of infected aortoiliac aneurysms.

              A 30-year retrospective review identified 13 patients treated for infected aneurysms of the abdominal aorta or iliac arteries, for an overall incidence of 0.65%. A constellation of clinical findings led to the correct preoperative diagnosis in 11 (85%) of 13 patients. Treatment methods included resection and in situ replacement grafting in seven patients, resection and extra-anatomic bypass in five patients, and resection-ligation in one patient. Four (31%) of 13 patients died within 30 days of operation, three of whom died of rupture. Overall, good results were achieved in five patients (38%), while poor results were noted in the remaining eight patients (62%). The determinants of outcome were aneurysm location or rupture, the presence of established infection, and the virulence of the infecting organism. In 10 (77%) of the 13 aneurysms, Salmonella species, Bacteroides fragilis, Staphylococcus aureus, and Pseudomonas aeruginosa accounted for all deaths, ruptures, and suprarenal aneurysm infections. These data suggest that patients with primary infections of the abdominal aorta or iliac arteries continue to present with advanced infections or aneurysm rupture that result in a high mortality.
                Bookmark

                Author and article information

                Journal
                Can J Infect Dis Med Microbiol
                Can J Infect Dis Med Microbiol
                PGI
                The Canadian Journal of Infectious Diseases & Medical Microbiology
                Pulsus Group Inc
                1712-9532
                1918-1493
                Sep-Oct 2015
                : 26
                : 5
                : 249-250
                Affiliations
                Division of Vascular and Endovascular Surgery, Ottawa Hospital and the University of Ottawa, Ottawa, Ontario
                Author notes
                Correspondence: Dr Tim Brandys, Division of Vascular and Endovascular Surgery, Civic Campus, Ottawa Hospital, Suite A2-80, 1053 Carling Avenue, Ottawa, Ontario K1Y 4E9. Telephone 613-761-4766, fax 613-761-5362, e-mail tbrandys@ 123456ottawahospital.on.ca
                Article
                cjidmm-26-249
                4644006
                ef1e9f36-df9d-4ce9-8b69-cf7a547b21b2
                Copyright© 2015 Pulsus Group Inc. All rights reserved

                This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) ( http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@ 123456pulsus.com

                History
                Categories
                Clinical Vignette

                Comments

                Comment on this article